New data repository created by ESAC for healthcare clinicians
ESAC, Inc. is launching the Proteomic Data Commons (PDC) within the National Cancer Institute's (NCI) Cancer Research Data Commons (CRDC) on the cancer.gov domain, enabling the mass gathering of life saving information.
"The PDC is a next-generation proteomic data repository within NCI's CRDC that facilitates proteogenomics to revolutionize precision medicine,” said ESAC project manager, Ratna Thangudu, Ph.D.
The PDC provides the largest collection of freely available cancer proteomic data on a highly scalable cloud-based infrastructure that facilitates bringing analysis tools to the data instead of the opposite.
The PDC makes it possible for any researcher to ask new and fundamental questions about cancer and provides much-needed tools to accelerate research and the development of personalized treatments for individual patients.
Cancer researchers can now easily access the multi-omics (proteomic, genomic, imaging, etc.) data from many sources across the CRDC's virtual, expandable infrastructure, thus lowering the entry barrier for anyone who wants to get involved in integrative research.
According to Michael Holck, Vice President of Software Engineering at ESAC, the PDC is hosted within the Amazon Web Services (AWS) cloud allowing for easy access anywhere in the world and provides extremely large scalability to accommodate large volumes of data and compute power for data analysis.
The PDC Data Browser provides an easy-to-use user interface to query the available data. In addition, there are robust APIs available for bioinformaticians to use to access data programmatically.
"We are excited to support the Cancer Research Data Commons and the larger cancer research community with the first public release of the Proteomic Data Commons," said ESAC president, Anand Basu. "We look forward to building upon this open science platform with input from data submitters and users in the coming months through new releases and much anticipated features in support of cancer proteogenomics research."
For more information about this news, visit https://pdc.cancer.gov/.